Proteomic screens

Show results for

Unknown (168)
Proteomics (72)
Genomics (54)
Transcriptomics (22)
Other (6)

Organisms

Allexis (64)
Arabidopsis thaliana (64)
Bos taurus (64)
Callinectes sapidus (64)
Drosophila melanogaster (64)
Entamoeba histolytica HM-1:IMSS-A (64)
Escherichia coli (64)
Homo sapiens (64)
Leishmania major strain Friedlin (64)
Listeria monocytogenes (64)
Medicago truncatula (64)
Meleagris gallopavo (64)
Methylohalobius crimeensis 10Ki (64)
Mus musculus (64)
Rattus norvegicus (64)
Saccharomyces cerevisiae (64)
Schizosaccharomyces pombe (64)
Shigella (64)
Shigella flexneri (64)
Sinorhizobium meliloti BL225C (64)
Solanum tuberosum (64)
Staphylococcus aureus (64)
Sus scrofa domesticus (64)
Zea mays (64)
Homo sapiens (31)
Mus musculus (8)
Pseudomonas aeruginosa PAO1 (1)
Escherichia coli (1)
synthetic construct (1)
Ovis aries (1)

Organisms

Homo sapiens (30)
Mus musculus (6)
Erythranthe guttata (1)
Pseudomonas aeruginosa PAO1 (1)
Escherichia coli (1)

Repository

pride (64)
ENA (45)
geo (35)
jPOST (3)
MassIVE (3)
biostudies-arrayexpress (2)
iProX (2)

Tissue

Cell culture (17)
Fibroblast (5)
Permanent cell line cell (4)
HEK-293T cell (3)
Kidney (3)
Liver (3)
Lung (3)
Blood plasma (2)
Bone marrow (2)
Cell suspension culture (2)
Epithelial cell (2)
Extracellular vesicle (2)
HeLa cell (2)
Heart (2)
Plant cell (2)
Semen (2)
B cell (1)
Blood cell (1)
Brain (1)
Breast (1)
Brown adipocyte (1)
Colon (1)
Embryo (1)
Embryonic stem cell (1)
Endothelial cell (1)
Eukaryotic cell (1)
Hepatocyte (1)
Leaf (1)
Leukocyte (1)
T cell (1)

Disease

Acute leukemia (2)
Breast cancer (2)
Colon cancer (2)
Human immunodeficiency virus infectious disease (2)
Abnormal breast morphology (1)
COVID-19 (1)
Cervix carcinoma (1)
Cholangiocarcinoma (1)
Chronic myeloid leukemia (1)
Hereditary spastic paraplegia 47 (1)
Hereditary spastic paraplegia 50 (1)
Hereditary spastic paraplegia 51 (1)
Hereditary spastic paraplegia 52 (1)
Human cytomegalovirus infection (1)
Hypertrophic cardiomyopathy (1)
Lung cancer (1)
Lung carcinoma (1)
Lymphoma (1)
Malignant neoplasm of ovary (1)
Multiple myeloma (1)
Non-small cell lung carcinoma (1)
Peripheral primitive neuroectodermal tumor (1)
Trypanosomiasis (1)
Trypanosomiasis (1)

Technology Type

Mass Spectrometry (64)
Shotgun proteomics (38)
Bottom-up proteomics (11)
Affinity purification coupled with mass spectrometry proteomics (7)
Data-independent acquisition (5)
Gel-based experiment (5)
Data-dependent acquisition (3)
SWATH MS (3)
MSE (2)
SRM/MRM (2)

Instrument Platform

Orbitrap Fusion (1)
Q Exactive HF (1)
Q Exactive Plus (1)

Publication Date

2026 (19)
2025 (17)
2022 (15)
2024 (13)
2020 (9)
2018 (9)
2021 (7)
2023 (7)
2016 (4)
2019 (4)
2014 (2)
2012 (1)
2017 (1)

First Public Date

2025 (14)
2026 (11)
2024 (5)
2018 (3)
2022 (2)
2021 (2)
2020 (2)
2019 (2)
2016 (2)
2023 (1)
2013 (1)

Classification

bacteria (2)

Modification

2x(15)N labeled L-lysine (2)
4x(15)N labeled L-arginine (2)

Study type

Transcription profiling by array (2)

Release Date

2024 (18)
2021 (18)
2022 (17)
2025 (15)
2016 (13)
2019 (11)
2023 (9)
2018 (9)
2014 (8)
2013 (8)
2020 (7)
2009 (6)
2015 (5)
2011 (5)
2012 (4)
2017 (4)
2010 (3)
2007 (3)
2006 (3)
2026 (2)
2008 (1)
2004 (1)

Lab affiliation

Cambridge Institute for Medical Research, University of Cambridge, Hills Road, Cambridge, CB2 0XY, UK (2)
Department of Biological Chemistry, University of California Los Angeles, Los Angeles, California (2)
Department of Molecular & Integrative Physiology,University of Michigan Medical School, 5325 Brehm Tower, 1000 Wall St., Ann Arbor, MI, 48105 (2)
Dept. of Molecular Biosciences, University of Texas at Austin, Texas 78712 USA (2)
Alzheimer’s Research UK UCL Drug Discovery Institute, University College London, Cruciform Building, Gower Street, London, WC1E 6BT, U.K. (1)
Bavarian Center for Biomolecular Mass Spectrometry (BayBioMS), Technical University of Munich (TUM), Freising, Germany (1)
Biochemistry and Molecular Biology, University of British Columbia, Canada (1)
Calico Life Sciences (1)
Cancer Research Unit, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead NSW Australia (1)
Cancer Signaling & Microenvironment Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States (1)
Center for Alzheimer's and Related Dementias (CARD), NIA and NINDS, NIH, Bethesda, Maryland, USA. (1)
Charité Universitätsmedizin, Department of Biochemistry, 10117 Berlin, Germany The Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK Max Planck Institute for Molecular Genetics, Berlin, Germany (1)
Cold Spring Harbor Laboratory (1)
College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, South Korea (1)
Department of Biological Engineering, MIT, Cambridge, USA Ragon Institute of Mass General, Harvard, and MIT, Cambridge, USA (1)
Department of Biology, Washington University in St. Louis, St. Louis, MO, USA (1)
Department of Human Molecular Genetics and Biochemistry Tel Aviv University School of Medicine Tel Aviv 69987, Israel (1)
Department of Immunology, Weizmann Institute of Science, Rehovot, Israel (1)
Department of Laboratory Medicine, University of California, San Francisco, USA (1)
Department of Molecular Microbiology, Washington University in St. Louis, St. Louis, MO, USA (1)
Department of Molecular Sciences, Macquarie University, North Ryde, NSW 2109, Australia (1)
Department of Pathology, Microbiology & Immunology, New York Medical College, Valhalla, NY, USA Lovelace Biomedical Institute, Albuquerque, NM 87108-5127, USA (1)
Department of Pathology, Microbiology & Immunology, New York Medical College, Valhalla, NY, USA Lovelace Biomedical Institute, Albuquerque, NM 87108-5127, USA. (1)
Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany (1)
EDyP, BGE, BIGT (Biosciences and Biotechnology Institute of Grenoble) (1)
Faculty of Medical Sciences, Institute for Cell and Molecular Biosciences, Newcastle upon Tyne, UK (1)
Fernando García Martínez, Ph.D. Proteomics Unit, Spanish National cancer Research Center, CNIO, MADRID, SPAIN (1)
Functional Proteomics, ICR (1)
German Cancer Research Center (DKFZ), Heidelberg, Germany Heidelberg University, Medical Faculty, Heidelberg, Germany (1)
Glycoproteomics Lab. Department of Parasitology Institute of Biomedical Sciences - University of São Paulo (1)

Previous page
1 / 33
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 33
Next page

Sort by:

Relevance

Page size

Systematic genetic and proteomic screens during gametogenesis identify H2BK34 methylation as an evolutionary conserved meiotic mark.

Not available

S-EPMC7493871 | biostudies-literature

Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing Sarcoma.

Not available

S-EPMC8563374 | biostudies-literature

Proteomic screens of SEL1L-HRD1 ER-associated degradation substrates reveal its vital importance in the biogenesis of glycosylphosphatidylinositol-anchored proteins

The SEL1L-HRD1 protein complex of endoplasmic reticulum (ER)-associated degradation (ERAD) plays indispensable roles for many physiological processes in a substrate-specific manner; however, the nature of endogenous substrates remains largely elusive. Here we have developed a unique proteomics strat...

ORGANISM(S): Homo sapiens (Human) Mus musculus (Mouse)

2023-12-17 | PXD041803 | Pride

Massively parallel genetic resistance screens

Here we describe the use of multiple forward genetic screens executed in parallel to identify those genes, and their cognate pathways, that when overexpressed, silenced or mutated confer resistance in BRAF mutant colon cancer to a BRAF/MEK/EGFR inhibitor combination. We demonstrate that this resista...

ORGANISM(S): Homo sapiens (Human)

2022-03-23 | PXD007781 | Pride

Colon Phosphoproteomics Cancer Tmt

Changes between Longissimus dorsi muscle from donkey, cow and goat assessed by Transcriptomic and Proteomic

PRJNA545859 | ENA

Proteomic screens of SEL1L-HRD1 ER-associated degradation substrates reveal its vital importance in the biogenesis of glycosylphosphatidylinositol-anchored proteins

ORGANISM(S): Homo sapiens (Human)

2023-12-17 | PXD041882 | Pride

Disease mutants Endogenous substrates Pigk Sel1l-hrd1 erad Proteomic screens Gpi-anchored proteins

Identifying human pre-mRNA cleavage and polyadenylation factors by genome-wide CRISPR screens using a dual fluorescence readthrough reporter.

Not available

S-EPMC11077057 | biostudies-literature